COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,429 Articles (22,835 medRxiv, 8,594 bioRxiv)

Most recent first Previous |  Page 1320: Articles 13191-13200  | Next

THE EFFECT OF BARICITANIB USAGE ON THE CLINICAL AND BIOCHEMICAL PROFILES OF COVID-19 PATIENTS- A RETROSPECTIVE OBSERVATIONAL STUDY
Amarnath, A., Das, A., Mutya, V. S. S., Ibrahim, I.
10.1101/2021.08.11.21261760 — Posted: 2021-08-13
How did people cope during the COVID-19 pandemic? A Structural Topic Modelling Analysis of Free-Text Data from 11,000 UK Adults
Wright, L., Fluharty, M. E., Steptoe, A., Fancourt, D.
10.1101/2021.08.13.21262002 — Posted: 2021-08-13
Rapid antigen testing as a reactive public health response to surges in SARS-CoV-2 outbreak risk in healthcare settings
Smith, D. R., Duval, A., Zahar, J. R., opatowski, l., TEMIME, L.
10.1101/2021.08.13.21261968 — Posted: 2021-08-13
Characterising the persistence of RT-PCR positivity and incidence in a community survey of SARS-CoV-2
Eales, O., Walters, C. E., Wang, H., Haw, D., Ainslie, K. E. C., Atchinson, C., Page, A., Prosolek, S., Trotter, A. J., Le Viet, T., Alikhan, N.-F., Jackson, L. M., Ludden, C., The COVID-19 Genomics UK (COG-UK) Consortium, , Ashby, D., Donnelly, C. A., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P., Riley, S.
10.1101/2021.08.12.21261987 — Posted: 2021-08-13
The production of anti-PF4 antibodies in anti-phospholipid antibody-positive patients is not affected by COVID-19 vaccination
Lonati, P., Bodio, C., Scavone, M., Martini, G., Pesce, E., Bandera, A., Lombardi, A., Gerosa, M., Franceschini, F., Tincani, A., Podda, G., Abrignani, S., Grifantini, R., Cattaneo, M., Borghi, M. O., Meroni, P. L.
10.1101/2021.08.12.21261976 — Posted: 2021-08-13
Factors influencing wellbeing in young people during COVID-19.
James, M., Jones, H., Baig, A., Marchant, E., Waites, T., Todd, C., Hughes, K., Brophy, S.
10.1101/2021.08.13.21261959 — Posted: 2021-08-13
COVID-19 vaccine uptake among older people in relation to sociodemographic factors: cohort results from southern Sweden
Inghammar, M., Moghaddassi, M., Rasmussen, M., Malmqvist, U., Kahn, F., Bjork, J.
10.1101/2021.08.12.21261981 — Posted: 2021-08-13
Seroprevalence of anti-SARS-CoV-2 antibodies six months into the vaccination campaign in Geneva, Switzerland
Stringhini, S., Zaballa, M.-E., Pullen, N., Perez-Saez, J., de Mestral, C., Loizeau, A., Lamour, J., Pennacchio, F., Wisniak, A., Dumont, R., Baysson, H., Richard, V., Lorthe, E., Semaani, C., Balavoine, J.-F., Pittet, D., Vuilleumier, N., Chappuis, F., Kherad, O., Azman, A. S., Posfay-Barbe, K., Kaiser, L., Guessous, I., the Specchio-COVID19 Study Group
10.1101/2021.08.12.21261929 — Posted: 2021-08-13
Efficacy of SARS-CoV-2 vaccine in thoracic cancer patients: a prospective study supporting a third dose in patients with minimal serologic response after two vaccine doses
GOUNANT, V., FERRE, V. M., SOUSSI, G., charpentier, C., FLAMENT, H., FIDOUH, N., COLLIN, G., NAMOUR, C., ASSOUN, S., BIZOT, A., BROUK, Z., VICAUT, E., TEXEIRA, L., DESCAMPS, D., ZALCMAN, G.
10.1101/2021.08.12.21261806 — Posted: 2021-08-13
Association of Naive B Cells with Humoral Response to SARS-CoV-2 Vaccination
Schulz, E., Hodl, I., Forstner, P., Hatzl, S., Sareban, N., Moritz, M., Fessler, J., Dreo, B., Uhl, B., Url, C., Grisold, A., Khalil, M., Kleinhappl, B., Enzinger, C., Stradner, M. H., Greinix, H., Schlenke, P., Steinmetz, I.
10.1101/2021.08.11.21261898 — Posted: 2021-08-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).